Arkolith/Insider Trading/MAZE/Form 4

Coloma Jason V

Chief Executive Officer, DirectorMaze Therapeutics, Inc. (MAZE) · full profile →Form 4 · filed May 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$847K
Net Open-Market Flow
-$847K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 26, 2026Sell(S)26K$26.02$666K351K
May 22, 2026Sell(S)5K$26.00$117K377K
May 22, 2026Sell(S)2K$26.00$64K29K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001676170-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML